Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging

被引:8
|
作者
Liesche-Starnecker, Friederike [1 ]
Prokop, Georg [1 ]
Yakushev, Igor [2 ]
Preibisch, Christine [3 ]
Delbridge, Claire [1 ]
Meyer, Hanno S. [4 ]
Aftahy, Kaywan [4 ]
Barz, Melanie [4 ]
Meyer, Bernhard [4 ]
Zimmer, Claus [3 ]
Schlegel, Juergen [1 ]
Wiestler, Benedikt [3 ,5 ]
Gempt, Jens [4 ]
机构
[1] Tech Univ Munich, Sch Med, Inst Pathol, Dept Neuropathol, Munich, Germany
[2] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Nucl Med, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Neuroradiol, Munich, Germany
[4] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Neurosurg, Ismaningerstr 22, D-81675 Munich, Germany
[5] Tech Univ Munich, TranslaTUM Zentralinst Translat Krebsforsch, Einsteinstr 25, Munich, Germany
关键词
CELL-DENSITY; BRAIN; GLIOMAS; VOLUME; TUMORS;
D O I
10.1186/s13550-021-00817-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Combining imaging modalities has become an essential tool for assessment of tumor biology in glioblastoma (GBM) patients. Aim of this study is to understand how tumor cellularity and neovascularization are reflected in O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography ([18F] FET PET) and magnetic resonance imaging (MRI) parameters, including cerebral blood volume (CBV), fractional anisotropy (FA) and mean diffusivity (MD). Methods: In this prospective cohort, 162 targeted biopsies of 43 patients with therapy-naive, isocitrate dehydrogenase (IDH) wildtype GBM were obtained after defining areas of interest based on imaging parameters [18F] FET PET, CBV, FA and MD. Histopathological analysis of cellularity and neovascularization was conducted and results correlated to imaging data. Results: ANOVA analysis showed a significant increase of CBV in areas with high neovascularization. For diffusion metrics, and in particular FA, a trend for inverse association with neovascularization was found. [18F] FET PET showed a significant positive correlation to cellularity, while CBV also showed a trend towards correlation with cellularity, not reaching significant levels. In contrast, MD and FA were negatively associated with cellularity. Conclusion: Our study confirms that amino acid PET and MR imaging parameters are indicative of histological tumor properties in glioblastoma and highlights the ability of multimodal imaging to assess tumor biology non-invasively.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging
    Friederike Liesche-Starnecker
    Georg Prokop
    Igor Yakushev
    Christine Preibisch
    Claire Delbridge
    Hanno S. Meyer
    Kaywan Aftahy
    Melanie Barz
    Bernhard Meyer
    Claus Zimmer
    Jürgen Schlegel
    Benedikt Wiestler
    Jens Gempt
    EJNMMI Research, 11
  • [2] [18F]FET-PET/CT as a prognostic factor in newly-diagnosed gliomas II and III
    Kertels, Olivia
    Stolzenburg, Antje
    Mihovilovic, Milena
    Kessler, Almuth
    Samnick, Samuel
    Monoranu, Camelia
    Lohr, Mario
    Buck, Andreas
    Lapa, Constantin
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [3] Recurrence Pattern Analysis by means of FET-PET after Radiochemotherapy newly diagnosed Glioblastoma: An Update
    Niyazi, M.
    Schnell, O.
    Suchorska, B.
    Schwarz, S. B.
    Ganswindt, U. M.
    Garny, S.
    Geisler, J.
    Bartenstein, P.
    Kreth, F. -W
    Tonn, J-C
    Belka, C.
    la Fougere, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 88 - 88
  • [4] Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
    Werner, Jan-Michael
    Weller, Johannes
    Ceccon, Garry
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena K.
    Schaefer, Niklas
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Marnitz, Simone
    Kabbasch, Christoph
    Gielen, Gerrit H.
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3704 - 3713
  • [5] CLINICAL PARAMETERS OUTWEIGH DIFFUSION- AND PERFUSION-DERIVED MRI PARAMETERS IN PREDICTING SURVIVAL IN NEWLY-DIAGNOSED GLIOBLASTOMA
    Burth, S.
    Kickingereder, P.
    Tichy, D.
    Bonekamp, D.
    Wick, A.
    Loew, S.
    Nowosielski, M.
    Wick, W.
    Bendszus, M.
    Radbruch, A.
    NEURO-ONCOLOGY, 2016, 18 : 34 - 34
  • [6] SPATIAL DISCREPANCIES BETWEEN FET PET AND CONVENTIONAL MRI IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Lohmann, P.
    Stavrinou, P.
    Lipke, K.
    Bauer, E. K.
    Ceccon, G.
    Werner, J.
    Fink, G. R.
    Shah, N. J.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2019, 21 : 74 - 74
  • [7] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Poulsen, Sidsel Hojklint
    Urup, Thomas
    Grunnet, Kirsten
    Christensen, Ib Jarle
    Larsen, Vibeke Andree
    Jensen, Michael Lundemann
    af Rosenschold, Per Munck
    Poulsen, Hans Skovgaard
    Law, Ian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (03) : 373 - 381
  • [8] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Sidsel Højklint Poulsen
    Thomas Urup
    Kirsten Grunnet
    Ib Jarle Christensen
    Vibeke Andrée Larsen
    Michael Lundemann Jensen
    Per Munck af Rosenschöld
    Hans Skovgaard Poulsen
    Ian Law
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 373 - 381
  • [9] Pattern for the relapse analysis using FET-PET after chemoradiotherapy on a re-diagnosed glioblastoma
    Niyazi, M.
    Schwarz, S.
    Ganswindt, U.
    Garny, S.
    Suchorska, B.
    Schnell, O.
    Kreth, F. -W.
    Tonn, J. -C.
    Geisler, J.
    La Fougere, C.
    Barrenstein, P.
    Siefert, A.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 115 - 115
  • [10] FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status
    Niyazi, Maximilian
    Schnell, Oliver
    Suchorska, Bogdana
    Schwarz, Silke Birgit
    Ganswindt, Ute
    Geisler, Julia
    Bartenstein, Peter
    Kreth, Friedrich-Wilhelm
    Tonn, Joerg-Christian
    Eigenbrod, Sabina
    Belka, Claus
    la Fougere, Christian
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 78 - 82